↓ Skip to main content

Cochrane Database of Systematic Reviews

Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs
1 blog
twitter
25 X users
wikipedia
2 Wikipedia pages
f1000
1 research highlight platform

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
295 Mendeley
citeulike
1 CiteULike
Title
Combined inhaled anticholinergics and short‐acting beta<sub>2</sub>‐agonists for initial treatment of acute asthma in children
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd000060.pub2
Pubmed ID
Authors

Benedict Griffiths, Francine M Ducharme

Abstract

There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists (SABAs) in children experiencing an asthma exacerbation. Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a slower onset of action and weaker bronchodilating effect, but may specifically relieve cholinergic bronchomotor tone and decrease mucosal edema and secretions. Therefore, the combination of inhaled anticholinergics with SABAs may yield enhanced and prolonged bronchodilation.

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 295 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
Colombia 1 <1%
Canada 1 <1%
Unknown 290 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 39 13%
Researcher 33 11%
Student > Bachelor 32 11%
Other 22 7%
Student > Postgraduate 15 5%
Other 49 17%
Unknown 105 36%
Readers by discipline Count As %
Medicine and Dentistry 105 36%
Nursing and Health Professions 26 9%
Pharmacology, Toxicology and Pharmaceutical Science 9 3%
Social Sciences 7 2%
Psychology 6 2%
Other 22 7%
Unknown 120 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2023.
All research outputs
#1,433,610
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,074
of 11,842 outputs
Outputs of similar age
#12,211
of 210,588 outputs
Outputs of similar age from Cochrane database of systematic reviews
#66
of 236 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,588 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.